| Name | Title | Contact Details |
|---|
Viridian Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2006. Formerly known as Miragen Therapeutics, the company rebranded in January 2021. Viridian is dedicated to discovering, developing, and commercializing treatments for serious and rare diseases, utilizing its expertise in antibody discovery and protein engineering. The company’s product pipeline includes Veligrotug (VRDN-001), a monoclonal antibody in Phase 3 clinical trials for thyroid eye disease, and VRDN-003, a next-generation IGF-1R monoclonal antibody also in Phase 3 trials for the same condition. Additionally, Viridian is developing a portfolio of engineered anti-FcRn inhibitors, such as VRDN-006 and VRDN-008, aimed at treating various autoimmune diseases. Viridians mission is to deliver transformative therapies for patients with underserved diseases, emphasizing innovation and patient-centricity.
Shryne Group Inc. is a Los Angeles-based cannabis holding company with a fully, vertically integrated asset and license portfolio covering the breadth of California, the largest legal cannabis market in the world. The enterprise is the result of the synergetic integration of profitable cannabis assets and veteran professionals who have come together for the opportunity to shape this industry. Our vision is informed by an intimate understanding of cannabis culture, its history and the collective expertise of decades of experience in diverse fields. Our STIIIZY product line is one of the best-selling cannabis brands in the market today. We are rooted in California, but currently have operations in Nevada and Washington - soon to be in Michigan, and distribution networks to future markets in more than 60 countries.
MicroPort® is a premier medical solutions provider, founded on the belief that every person has the right to high-quality medical treatment. For over 26 years, we have been breaking barriers and accelerating access to life-changing technologies. Our commitment to innovation is powered by deep collaboration with the medical community, driving us to develop solutions that consistently put patients first. We believe that its the little details that make life special. Thats why we pay the utmost attention to every small detail of our medical technologies, ensuring that millions of lives everywhere can make every little moment a special one. Today, we operate in over 100 countries and 20,000 hospitals, providing advanced solutions for more than 200 diseases across 12 key therapeutic areas, impacting millions of lives globally. With significant R&D investments and a dedicated, skilled global workforce, MicroPort® is shaping the future of healthcare We are steadfast in our mission to ensure better and longer lives for patients worldwide. Discover how were making a difference at www.microport.com. Headquartered in Shanghai, with subsidiaries based around the world, we have a global footprint of R&D and manufacturing facilities across China, United States, France, Italy and Dominican Republic. Today, through the lens of a global organization of enterprises sharing resources and expertise with an agile independence, we see an exciting path forward. One that addresses the most challenging healthcare issues, while allowing us to explore ways to impact even more lives every second. Read our community guidelines: https://microport.com/about-us/corporate-social-responsibility/microport-social-media-terms-of-use
Great American Restoration Service is a East Meadow, NY-based company in the Business Services sector.
Jensen Keddington is a Salt Lake City, UT-based company in the Business Services sector.